GENTA INCORPORATED /DE/
NT 10-K, 1998-03-31
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: HYMEDIX INC, 10-K, 1998-03-31
Next: DECRANE AIRCRAFT HOLDINGS INC, 10-K, 1998-03-31




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12B-25
                         Commission File Number 0-19635
                           NOTIFICATION OF LATE FILING

(Check One):        |X|   Form 10-K  |_| Form 11-K  |_| Form 20-F  |_| Form 10-Q
                                                                  |_| Form N-SAR

                    For Period Ended: December 31, 1997

                    [ ] Transition Report on Form 10-K 

                    [ ] Transition Report on Form 20-F

                    [ ] Transition Report on Form 11-K

                    [ ] Transition Report on Form 10-Q

                    [ ] Transition Report on Form N-SAR

                    For the Transition Period Ended:____________________________

- --------------------------------------------------------------------------------
          Read instruction before preparing form. Please print or type.

NOTHING  IN THIS  FORM  SHALL BE  CONSTRUED  TO IMPLY  THAT THE  COMMISSION  HAS
VERIFIED ANY INFORMATION CONTAINED HEREIN.
- --------------------------------------------------------------------------------

If the notification  relates to a portion of the filing checked above,  identify
the item(s) to which the notification relates:

- --------------------------------------------------------------------------------

PART I - REGISTRANT INFORMATION

     Genta Incorporated
- --------------------------------------------------------------------------------
Full Name of Registrant


- --------------------------------------------------------------------------------
Former Name if Applicable

     3550 General Atomics Court
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

     San Diego, CA 92121
- --------------------------------------------------------------------------------
City, State and Zip Code

PART II -- RULE 12B-25(B) AND (C)

If the subject report could not be filed without  unreasonable effort or expense
and the  registrant  seeks  relief  pursuant to Rule 12b- 25(b),  the  following
should be completed. (Check box if appropriate)

          [x]  (a)  The reasons  described in  reasonable  detail in Part III of
                    this  form  could  not be  eliminated  without  unreasonable
                    effort or expense;
          [x]  (b)  The subject annual report,  semi-annual  report,  transition
                    report on Form  10-K,  Form  20-F,  11-K or Form  N-SAR,  or
                    portion  thereof,  will be filed on or before the  fifteenth
                    calendar  day  following  the  prescribed  due date;  or the
                    subject  quarterly report or transition report on Form 10-Q,
                    or  portion  thereof  will be filed on or  before  the fifth
                    calendar day following the prescribed due date; and
          [ ]  (c)  The accountant's statement or other exhibit required by Rule
                    12b-25(c) has been attached if applicable.

<PAGE>

PART III -- NARRATIVE

State below in reasonable  detail the reasons why Form 10-K,  11-K,  20-F, 10-Q,
N-SAR,  or the transition  report portion  thereof could not be filed within the
prescribed time period. (Attach Extra Sheets if Needed)

See Attachment I

PART IV -- OTHER INFORMATION

(1)     Name  and  telephone  number  of  person  to  contact  in regard to this
        notification

             Monica C. Lord, Esq.             (212)              715-9348
        ------------------------------   ---------------   ---------------------
                  (Name)                   (Area Code)       (Telephone Number)

(2)     Have all other  periodic  reports  required under Section 13 or 15(d) of
        the  Securities  Exchange  Act of 1934 or Section  30 of the  Investment
        Company Act of 1940 during the  preceding  12 months or for such shorter
        period that the  registrant  was  required to file such  report(s)  been
        filed? If the answer is no, identify report(s). |X| Yes |_| No

- --------------------------------------------------------------------------------


(3)     Is it anticipated  that any significant  change in results of operations
        from the corresponding period for the last fiscal year will be reflected
        by the  earnings  statements  to be included  in the  subject  report or
        portion thereof? |X| Yes |_| No

        If so, attach an explanation of the anticipated change, both narratively
        and  quantitatively,  and,  if  appropriate,  state  the  reasons  why a
        reasonable estimate of the results cannot be made.

                      See Attachment II
================================================================================

                                     Genta Incorporated
       -------------------------------------------------------------------------
                        (Name of Registrant as Specified in Charter)

Has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.


Date   March 30, 1998              By  /s/ Kenneth G. Kasses
     ---------------------------      ------------------------------------------
                                        Kenneth G. Kasses, Ph.D.
                                        President and Chief Executive Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION

- --------------------------------------------------------------------------------
INTENTIONAL  MISSTATEMENTS  OR OMISSIONS  OF FACT  CONSTITUTE  FEDERAL  CRIMINAL
VIOLATIONS (SEE 18 U.S.C. 1001).
- --------------------------------------------------------------------------------

<PAGE>

                              Genta Incorporated (the "Company")
                                         Form 12b-25
              Annual Report on Form 10-K for the Period Ended December 31, 1997


                                  ATTACHMENT I

The  Company is not able to file its  Annual  Report on Form 10-K for the period
ended December 31, 1997 (the "Annual  Report") within the prescribed time period
without  unreasonable effort or expense. The Company has been unable to complete
the Annual  Report in a timely  fashion  due to delays  caused by  unanticipated
attrition  of  the  Company's  controller  and  other  administrative  personnel
subsequent  to the end of fiscal year 1997.  However,  the Company will file the
Annual Report within the time prescribed by Rule 12b-25.


                                  ATTACHMENT II

The Company has  experienced a significant  change in results of operations from
the corresponding period for the last fiscal year related to the following:

The Company raised proceeds of approximately  $16.2 million in June 1997 through
the private  placement of Series D  convertible  preferred  stock.  The Series D
convertible  preferred  stock was  convertible  at a 50% discount to the average
Nasdaq  closing  price for five  days  preceding  the close of the  transaction.
Additionally, the Series D preferred stock has a liquidation preference totaling
$31,779,300.  Due to the  increase  in  value  associated  with  the  discounted
conversion terms and the liquidation preference of the Series D preferred stock,
the Company has accounted for such increase by charging $16,158,000 to dividends
imputed on  preferred  stock in 1997.  Such  charge  represents  an  increase of
approximately $13.8 million over a similar charge in 1996.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission